IvyRock Asset Management (HK) Ltd

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1809525 SHEUNG WAN, K3

Position in NTLA

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$169,200

-$85,020 QoQ

Shares Held

10,000

-49.6% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#225

of 327 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

IvyRock Asset Management (HK) Ltd holds $24,322,044 across 5 Biotechnology names. NTLA ranks #4 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LEGN	Legend Biotech Corp	801,000	$23,132,880
2	ARWR	Arrowhead Pharmaceuticals, Inc.	7,000	$570,570
3	BEAM	Beam Therapeutics Inc.	8,600	$295,152
4	NTLA	Intellia Therapeutics, Inc. This page	10,000	$169,200
5	PRME	Prime Medicine, Inc.	41,800	$154,242

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$169,200	10,000	-49.6%	Shares	Sole	2026-08-04
2026-03-31	$254,220	19,830	+2.6%	Shares	Sole	2026-05-07
2025-12-31	$173,776	19,330	+34.9%	Shares	Sole	2026-02-11
2025-09-30	$247,479	14,330	—	Shares	Sole	2025-11-12
No filing history on record for this holder in this stock.